Application of Markov model in post-marketing pharmacoeconomic evaluation of traditional Chinese medicine.
- Author:
Xin WANG
1
;
Xia SU
;
Wentao SUN
;
Yanming XIE
;
Yongyan WANG
Author Information
1. Beijing Bionovo Medicine Development Co., Ltd., Beijing 100024, China. wangxin@bionovo.com.cn
- Publication Type:Journal Article
- MeSH:
Economics, Pharmaceutical;
Markov Chains;
Medicine, Chinese Traditional;
economics;
Product Surveillance, Postmarketing
- From:
China Journal of Chinese Materia Medica
2011;36(20):2844-2847
- CountryChina
- Language:Chinese
-
Abstract:
In post-marketing study of traditional Chinese medicine (TCM), pharmacoeconomic evaluation has an important applied significance. However, the economic literatures of TCM have been unable to fully and accurately reflect the unique overall outcomes of treatment with TCM. For the special nature of TCM itself, we recommend that Markov model could be introduced into post-marketing pharmacoeconomic evaluation of TCM, and also explore the feasibility of model application. Markov model can extrapolate the study time horizon, suit with effectiveness indicators of TCM, and provide measurable comprehensive outcome. In addition, Markov model can promote the development of TCM quality of life scale and the methodology of post-marketing pharmacoeconomic evaluation.
